Cargando…
Derivation and validation of a risk classification tree for patients with synovial sarcoma
BACKGROUND: Synovial sarcoma (SS) accounts for 8%–10% of all soft‐tissue sarcomas. Clinical presentation and outcomes vary, yet discrete risk groups based on validated prognostic indices are not defined for the full spectrum of patients with SS. METHODS: We performed a retrospective cohort study usi...
Autores principales: | Neel, Dylan V., Ma, Clement, Collins, Natalie B., Hornick, Jason L., Demetri, George D., Shulman, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844650/ https://www.ncbi.nlm.nih.gov/pubmed/35670308 http://dx.doi.org/10.1002/cam4.4909 |
Ejemplares similares
-
GI Synovial Sarcomas
por: Sinniah, Rajeev Palar, et al.
Publicado: (2012) -
Synovial sarcoma of the mandible
por: Khalili, Maryam, et al.
Publicado: (2012) -
Pulmonary synovial sarcoma
por: Gupta, Ankit, et al.
Publicado: (2018) -
Synovial Sarcoma of the Hand
por: Ohan, Hovsep, et al.
Publicado: (2020) -
Synovial-cell sarcoma
por: Nugud, Ahmed, et al.
Publicado: (2019)